Liver X receptor agonists as a treatment for atherosclerosis

Author： Bennett D Jonathan   Cooke Andrew J   Edwards Andrew S   Moir Elizabeth   Ray Peter C  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.14, Iss.7, 2004-07, pp. : 967-982

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on non-steroidal liver X receptor agonists and their potential use in the treatment of atherosclerosis

By Bennett D Jonathan   Brown Lindsay D   Cooke Andrew J   Edwards Andrew S  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 12, 2006-12 ,pp. : 1673-1699

Informa Healthcare

Access to resources Recommend Favorite

Dopamine D Receptor Agonists: The Way Forward for the Treatment of Parkinson's Disease?

By Vermeulen R.J.   Drukarch B.   Wolters E.C.   Stoof J.C.  

CNS Drugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 83-91

Adis International

Access to resources Recommend Favorite

Muscarinic Receptor Agonists in Alzheimer's Disease: More Than Just Symptomatic Treatment?

By Fisher A.  

CNS Drugs, Vol. 12, Iss. 3, 1999-09 ,pp. : 197-214

Adis International

Access to resources Recommend Favorite

Muscarinic Receptor Agonists and Antagonists in the Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3353-3361

Bentham Science Publishers

Access to resources Recommend Favorite

Melanocortin - 4 Receptor Agonists for the Treatment of Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1121-1130

Bentham Science Publishers

Access to resources Recommend Favorite